{"id":380272,"date":"2020-11-12T16:08:41","date_gmt":"2020-11-12T21:08:41","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=380272"},"modified":"2020-11-12T16:08:41","modified_gmt":"2020-11-12T21:08:41","slug":"neuronetics-to-present-at-the-canaccord-genuity-virtual-medtech-diagnostics-forum","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/neuronetics-to-present-at-the-canaccord-genuity-virtual-medtech-diagnostics-forum\/","title":{"rendered":"Neuronetics to Present at the Canaccord Genuity Virtual MedTech &amp; Diagnostics Forum"},"content":{"rendered":"<div class=\"mw_release\">\n<p>MALVERN, Pa., Nov.  12, 2020  (GLOBE NEWSWIRE) &#8212; Neuronetics, Inc.\u00a0(NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders, today announced that the management team will present at the Canaccord Genuity Virtual MedTech &amp; Diagnostics Forum on Thursday, November 19, 2020 at 12:30pm ET. <\/p>\n<p>A live audio webcast of the conference presentation will be available online at the investor relations page of the Company\u2019s website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=krwl-Y18vAxD5s5RdPc7oLmEjSL0v8wZyr7v7g5PsUcQPkT5jeWgI6cLMtA1lSN373U8_X779gBvH1bubFF0YxrbToGMqFVptTh17G_l9aY=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><strong>ir.neuronetics.com<\/strong><\/a>. A replay of the webcast will be archived on the website for approximately 90 days.<\/p>\n<p><strong>About\u00a0Neuronetics<\/strong><\/p>\n<p>Neuronetics, Inc. is a commercial-stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Our first commercial product, the NeuroStar\u00ae Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulation, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The system is cleared by the United States Food and Drug Administration, or FDA, for the treatment of major depressive disorder in adult patients who have failed to achieve satisfactory improvement from prior antidepressant medication in the current episode. NeuroStar is also available in other parts of the world, including Japan, where it is listed under Japan\u2019s national health insurance. Additional information can be found at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=g_S-Kl2CJAo9MYq7YoadybeNKICQOLaW81YPQi_cjL0iSUU61ust_ArUk7yoKs00HTvd7RQbSIvuZB6jh0wdL9YwJn4GlP2qSMpg5ofPaCc=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><strong><u>www.neuronetics.com<\/u><\/strong><\/a>.<\/p>\n<p>Investor Contact:<\/p>\n<p>Mark R. Klausner<br \/>Westwicke Partners<br \/>443-213-0501<br \/><strong><u><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=j9NSHOwNER1DFO2x0r4AF51i4vBf8udXSRDQgdh1QiLPmmn7nUeYZ9X3Fu2BSvwYtMIb50RvW3v-j7je1KUPGmjYBawH_1flMVbj6sM09Y8=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">ir@neuronetics.com<\/a><\/u><\/strong><\/p>\n<p>Media Contact:<\/p>\n<p>Chelsey Manko<br \/>Vault Communications<br \/>610-455-2778<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=M9TsHYL7uSfd1dKQB3eeSEzGqfZTdUpoIne3MhGvL_s7G3z-U084tAOA8pwv2BjIO0bd_zjlvO29felTqLLjdGitQbAxfGlQZUjBM6c2SlDoSeR24tq4retBBspv7Kx3\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><strong>cmanko@vaultcommunications.com<\/strong><\/a><\/p>\n<p>      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4NTI0MiMzODI0OTU1IzIxMTA0NDA=\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>MALVERN, Pa., Nov. 12, 2020 (GLOBE NEWSWIRE) &#8212; Neuronetics, Inc.\u00a0(NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders, today announced that the management team will present at the Canaccord Genuity Virtual MedTech &amp; Diagnostics Forum on Thursday, November 19, 2020 at 12:30pm ET. A live audio webcast of the conference presentation will be available online at the investor relations page of the Company\u2019s website at ir.neuronetics.com. A replay of the webcast will be archived on the website for approximately 90 days. About\u00a0Neuronetics Neuronetics, Inc. is a commercial-stage medical technology company focused on designing, developing, and marketing products that improve the quality &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/neuronetics-to-present-at-the-canaccord-genuity-virtual-medtech-diagnostics-forum\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Neuronetics to Present at the Canaccord Genuity Virtual MedTech &amp; Diagnostics Forum&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-380272","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Neuronetics to Present at the Canaccord Genuity Virtual MedTech &amp; Diagnostics Forum - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/neuronetics-to-present-at-the-canaccord-genuity-virtual-medtech-diagnostics-forum\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Neuronetics to Present at the Canaccord Genuity Virtual MedTech &amp; Diagnostics Forum - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"MALVERN, Pa., Nov. 12, 2020 (GLOBE NEWSWIRE) &#8212; Neuronetics, Inc.\u00a0(NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders, today announced that the management team will present at the Canaccord Genuity Virtual MedTech &amp; Diagnostics Forum on Thursday, November 19, 2020 at 12:30pm ET. A live audio webcast of the conference presentation will be available online at the investor relations page of the Company\u2019s website at ir.neuronetics.com. A replay of the webcast will be archived on the website for approximately 90 days. About\u00a0Neuronetics Neuronetics, Inc. is a commercial-stage medical technology company focused on designing, developing, and marketing products that improve the quality &hellip; Continue reading &quot;Neuronetics to Present at the Canaccord Genuity Virtual MedTech &amp; Diagnostics Forum&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/neuronetics-to-present-at-the-canaccord-genuity-virtual-medtech-diagnostics-forum\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2020-11-12T21:08:41+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4NTI0MiMzODI0OTU1IzIxMTA0NDA=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/neuronetics-to-present-at-the-canaccord-genuity-virtual-medtech-diagnostics-forum\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/neuronetics-to-present-at-the-canaccord-genuity-virtual-medtech-diagnostics-forum\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Neuronetics to Present at the Canaccord Genuity Virtual MedTech &amp; Diagnostics Forum\",\"datePublished\":\"2020-11-12T21:08:41+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/neuronetics-to-present-at-the-canaccord-genuity-virtual-medtech-diagnostics-forum\\\/\"},\"wordCount\":277,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/neuronetics-to-present-at-the-canaccord-genuity-virtual-medtech-diagnostics-forum\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA4NTI0MiMzODI0OTU1IzIxMTA0NDA=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/neuronetics-to-present-at-the-canaccord-genuity-virtual-medtech-diagnostics-forum\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/neuronetics-to-present-at-the-canaccord-genuity-virtual-medtech-diagnostics-forum\\\/\",\"name\":\"Neuronetics to Present at the Canaccord Genuity Virtual MedTech &amp; Diagnostics Forum - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/neuronetics-to-present-at-the-canaccord-genuity-virtual-medtech-diagnostics-forum\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/neuronetics-to-present-at-the-canaccord-genuity-virtual-medtech-diagnostics-forum\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA4NTI0MiMzODI0OTU1IzIxMTA0NDA=\",\"datePublished\":\"2020-11-12T21:08:41+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/neuronetics-to-present-at-the-canaccord-genuity-virtual-medtech-diagnostics-forum\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/neuronetics-to-present-at-the-canaccord-genuity-virtual-medtech-diagnostics-forum\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/neuronetics-to-present-at-the-canaccord-genuity-virtual-medtech-diagnostics-forum\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA4NTI0MiMzODI0OTU1IzIxMTA0NDA=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA4NTI0MiMzODI0OTU1IzIxMTA0NDA=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/neuronetics-to-present-at-the-canaccord-genuity-virtual-medtech-diagnostics-forum\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Neuronetics to Present at the Canaccord Genuity Virtual MedTech &amp; Diagnostics Forum\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Neuronetics to Present at the Canaccord Genuity Virtual MedTech &amp; Diagnostics Forum - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/neuronetics-to-present-at-the-canaccord-genuity-virtual-medtech-diagnostics-forum\/","og_locale":"en_US","og_type":"article","og_title":"Neuronetics to Present at the Canaccord Genuity Virtual MedTech &amp; Diagnostics Forum - Market Newsdesk","og_description":"MALVERN, Pa., Nov. 12, 2020 (GLOBE NEWSWIRE) &#8212; Neuronetics, Inc.\u00a0(NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders, today announced that the management team will present at the Canaccord Genuity Virtual MedTech &amp; Diagnostics Forum on Thursday, November 19, 2020 at 12:30pm ET. A live audio webcast of the conference presentation will be available online at the investor relations page of the Company\u2019s website at ir.neuronetics.com. A replay of the webcast will be archived on the website for approximately 90 days. About\u00a0Neuronetics Neuronetics, Inc. is a commercial-stage medical technology company focused on designing, developing, and marketing products that improve the quality &hellip; Continue reading \"Neuronetics to Present at the Canaccord Genuity Virtual MedTech &amp; Diagnostics Forum\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/neuronetics-to-present-at-the-canaccord-genuity-virtual-medtech-diagnostics-forum\/","og_site_name":"Market Newsdesk","article_published_time":"2020-11-12T21:08:41+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4NTI0MiMzODI0OTU1IzIxMTA0NDA=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/neuronetics-to-present-at-the-canaccord-genuity-virtual-medtech-diagnostics-forum\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/neuronetics-to-present-at-the-canaccord-genuity-virtual-medtech-diagnostics-forum\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Neuronetics to Present at the Canaccord Genuity Virtual MedTech &amp; Diagnostics Forum","datePublished":"2020-11-12T21:08:41+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/neuronetics-to-present-at-the-canaccord-genuity-virtual-medtech-diagnostics-forum\/"},"wordCount":277,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/neuronetics-to-present-at-the-canaccord-genuity-virtual-medtech-diagnostics-forum\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4NTI0MiMzODI0OTU1IzIxMTA0NDA=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/neuronetics-to-present-at-the-canaccord-genuity-virtual-medtech-diagnostics-forum\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/neuronetics-to-present-at-the-canaccord-genuity-virtual-medtech-diagnostics-forum\/","name":"Neuronetics to Present at the Canaccord Genuity Virtual MedTech &amp; Diagnostics Forum - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/neuronetics-to-present-at-the-canaccord-genuity-virtual-medtech-diagnostics-forum\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/neuronetics-to-present-at-the-canaccord-genuity-virtual-medtech-diagnostics-forum\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4NTI0MiMzODI0OTU1IzIxMTA0NDA=","datePublished":"2020-11-12T21:08:41+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/neuronetics-to-present-at-the-canaccord-genuity-virtual-medtech-diagnostics-forum\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/neuronetics-to-present-at-the-canaccord-genuity-virtual-medtech-diagnostics-forum\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/neuronetics-to-present-at-the-canaccord-genuity-virtual-medtech-diagnostics-forum\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4NTI0MiMzODI0OTU1IzIxMTA0NDA=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4NTI0MiMzODI0OTU1IzIxMTA0NDA="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/neuronetics-to-present-at-the-canaccord-genuity-virtual-medtech-diagnostics-forum\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Neuronetics to Present at the Canaccord Genuity Virtual MedTech &amp; Diagnostics Forum"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/380272","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=380272"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/380272\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=380272"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=380272"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=380272"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}